The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial.
 
Christian F. Singer
Honoraria - AstraZeneca/MedImmune; Daiichi Sankyo Europe GmbH; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Novartis; Sanofi/Aventis
Speakers' Bureau - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Myriad Genetics; Novartis; Roche
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - Novartis; Roche
 
Franz König
No Relationships to Disclose
 
Stephanie Kacerovsky-Strobl
No Relationships to Disclose
 
Sabine Danzinger
Honoraria - Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Lilly O.; Pfizer; Roche
 
Christine Brunner
Honoraria - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Seagan
Consulting or Advisory Role - Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Christoph Suppan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Lilly O.; Novartis; Pierre Fabre
 
Christine Deutschmann
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Novartis; Roche
 
Marija Balic
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Samsung
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Samsung
Speakers' Bureau - Amgen; AstraZeneca; Celgene; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo; Lilly O.; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Abbvie; Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Daniel Egle
Honoraria - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagan
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical
 
Evandro de Azambuja
Honoraria - Libbs (Inst); Novartis/Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech; SeaGen; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca (Inst); Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Serena Di Cosimo
Consulting or Advisory Role - MEDSIR; Pierre Fabre
Speakers' Bureau - AstraZeneca
Research Funding - AIRC
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Daiichi-Sankyo; LifeBrain; Lilly; Menarini Group; Tolmar; Veracyte